Abstract: Embodiments of the disclosure provide a method, an apparatus, a device, and a storage medium for resource configuration. The method includes obtaining an indication for the number of nodes of a NUMA node of a processor socket; dividing acceleration resources of an accelerator into at least one acceleration resource queue based on the number of nodes; and by associating the at least one acceleration resource queue to a respective NUMA node included in the processor socket, causing a plurality of processor cores divided into the respective NUMA node to use the at least one acceleration resource queue based on the association. Thus, the availability of the accelerator may be improved.

Abstract: A display panel and a display device are provided. The display panel has a display area and a binding area. The display panel includes a color film substrate and an array substrate, wherein the color film substrate includes a near-field communication antenna, the near-field communication antenna includes a coil structure, and the coil structure is at least partially located in the display area; and the array substrate includes a first base substrate, a channel region and a non-channel region, wherein an orthographic projection of the coil structure on the first base substrate is located within an orthographic projection of the non-channel region on the first base substrate.

Abstract: Disclosed are an emotional evolution method and terminal for a virtual avatar in educational metaverse.

Abstract: Provided is a liquid crystal handwriting board. The liquid crystal handwriting board includes: a liquid crystal panel, a photosensitive assembly, and a control assembly; wherein the liquid crystal panel includes a first substrate and a second substrate that are opposite; the photosensitive assembly includes a plurality of photosensitive elements; and the control assembly is electrically connected to the liquid crystal panel and the photosensitive assembly, and is configured to determine position information of a pixel region for erasure by detecting position information of target light irradiated to the liquid crystal panel by the photosensitive assembly and supply a pixel voltage to the plurality of pixel electrodes in the pixel region for erasure, such that a voltage difference is present between the plurality of pixel electrodes in the pixel region for erasure and the common electrode.

Abstract: Systems and techniques are described for large field of view imaging. A device's first image sensor captures a first image based on first light from a scene redirected by a light redirection element (e.g., a first prism and/or first reflective surface), and the device's second image sensor captures a second image based on second light from the scene redirected by the light redirection element (e.g., a second prism and/or second reflective surface). The device can modify the first image and/or second image using perspective distortion correction and/or to align one or more properties of two respective depictions of a shared portion of a scene in the two images. The one or more properties can include brightness, contrast, positioning, sharpness, tint, hue, and/or saturation. The device can generate a combined image with a large field of view and smooth transitions by combining the first image and the second image.

Abstract: Provided are an ovary-targeting polypeptide, a derivative of the polypeptide, and the use of the polypeptide in the preparation of a drug or reagent for treating ovarian related reproductive diseases and preventing and treating the in-vivo or in-vitro aging of oocytes. The diseases comprise menstrual cycle disorder, polycystic ovary syndrome, androgenic phenotype, hair loss, abnormal metabolism, ovarian insufficiency, premature ovarian failure, ovulation failure, abnormal glucose metabolism, and abnormal lipid metabolism, preferably, hyperglycemia and insulin resistance. In addition, the polypeptide is expected to prolong the preservation time and improve the preservation quality of oocytes or fertilized eggs in the field of assisted reproduction.

Abstract: Provided is a liquid crystal handwriting panel. The liquid crystal handwriting panel includes: a first substrate and a second substrate that are opposite to each other, and a liquid crystal layer between the first substrate and the second substrate; wherein the first substrate includes: a first base substrate, a touch electrode layer on a side of the first base substrate, and a first drive electrode layer on a side of the first base substrate; the second substrate includes: a second base substrate, a second drive electrode layer on a side of the second base substrate, and a shielding layer on a side of the second base substrate.

Abstract: A liquid crystal handwriting board is provided. The liquid crystal handwriting board includes a first substrate and a second substrate that are disposed opposite to each other, and a liquid crystal layer disposed between the first substrate and the second substrate; wherein the first substrate includes: a first base substrate, and a transistor and a pixel electrode disposed at a side, proximal to the second substrate, of the first base substrate, the transistor being electrically connected to the pixel electrode; wherein the transistor includes a channel region, wherein a ratio of an area of the channel region to an on-current of the transistor is greater than a ratio of an area of a channel region of a reference transistor to an on-current of the reference transistor.

Abstract: There are provided systems and methods for classifying a substructure in graph data using textual descriptions derived from the graph data and hash maps generated from the textual descriptions. One or more descriptions that describe a plurality of transactions are generated based on a sequence of nodes in a set of nodes identified in a corresponding transaction of the plurality of transactions. The set of nodes represents features of the corresponding transaction. A plurality of instances is identified from the descriptions, and each instance may include a substructure including two or more nodes connected via at least one edge. For each instance, a key and a value are generated based on a hash for the instance to generate a hash map. A specific transaction is classified as an abnormal transaction based on a particular key that is excluded from the hash map.

Abstract: The present disclosure is related to systems and methods for processing X-ray images. A method for processing an X-ray image may include obtaining an X-ray image; and determining a metal image based on the X-ray image by using a trained metal detection model. The metal image includes information of a metal object in the X-ray image.

Abstract: A method for preparing a supercritical fluid by deep-sea pressure is provided and belongs to the technical field of supercritical fluid preparation. The method includes the following steps of: placing a low-pressure fluid in a closed flexible container, sending the closed flexible container down to a location of a sea at a depth where a seawater pressure meets a requirement by using a powered or unpowered traction device, leaving the flexible container standing still until a volume of the flexible container does not change, wrapping the closed flexible container with a rigid pressure-bearing container, transferring the closed flexible container to the sea surface by the powered or unpowered traction device, and taking out the fluid in the flexible container as supercritical fluid. Then the supercritical fluid is produced. Therefore, the process of preparing supercritical (high pressure) liquid in the deep-sea is safer and more stable than the preparation way on land.

Abstract: A magnetic confinement fusion reactor includes a host hall, and a host including a Dewar system, a cold shield system, a superconducting magnet system, a vacuum chamber system, a divertor system, a blanket system, a remote operation system, and a maintenance system. The superconducting magnet system includes a central solenoid magnet, a poloidal field magnet, and a toroidal field magnet. The central solenoid magnet is configured to provide necessary volt-seconds. The poloidal field magnet is configured to generate a poloidal magnetic field. The toroidal field magnet is configured to generate a toroidal magnetic field. The plasma is confined by the toroidal magnetic field and the poloidal magnetic field. The vacuum chamber system is provided with a neutron shielding block to protect the superconducting magnets from being damaged by fusion neutrons.

Abstract: A magnetic confinement fusion reactor includes a host hall, and a host including a Dewar system, a cold shield system, a superconducting magnet system, a vacuum chamber system, a divertor system, a blanket system, a remote operation system, and a maintenance system. The superconducting magnet system includes a central solenoid magnet, a poloidal field magnet, and a toroidal field magnet. The central solenoid magnet is configured to provide necessary volt-seconds. The poloidal field magnet is configured to generate a poloidal magnetic field. The toroidal field magnet is configured to generate a toroidal magnetic field. The plasma is confined by the toroidal magnetic field and the poloidal magnetic field. The vacuum chamber system is provided with a neutron shielding block to protect the superconducting magnets from being damaged by fusion neutrons.

Abstract: The present invention relates to crystalline forms I and II of the compound 2-N-4,6-di-O-tributyryl-D-glucosamine, preparation methods and uses thereof, wherein the crystalline forms I and II obtained from the present invention have high water solubility, crystalline stability and can be better applied in pharmacy.

Abstract: The disclosure relates to bifunctional KRAS-modulating compounds having the structure K-L-T, where K is a targeting group that binds specifically to a KRAS protein (mutant or wild-type), T is an E3-ligase binding group, and L is absent or is a bivalent linking group that connects K and T together via a covalent linkage. Compounds and pharmaceutical compositions thereof can promote degradation of KRAS protein (mutant or wild-type) in a cell and are thus useful for treating, inhibiting, and preventing KRAS-associated diseases, disorders and conditions, including cancers.

Abstract: The disclosure relates to KRAS inhibitor compounds having the structure of Formula (I), pharmaceutical compositions thereof, and methods of use thereof for inhibiting, treating, and/or preventing KRAS-associated diseases, disorders and conditions.

Abstract: The disclosure relates to KRASG12D inhibitor compounds having the structure of Formula (A) or Formula (B), pharmaceutical compositions thereof, and methods of use thereof for inhibiting, treating, and/or preventing KRASG12D mutation-associated diseases, disorders and conditions.

Abstract: The disclosure relates to bifunctional KRAS-G12D-modulating compounds having the structure W-L-T, where W is a targeting group that binds specifically to KRAS-G12D protein, T is an E3-ligase binding group, and L is absent or is a bivalent linking group that connects W and T together via a covalent linkage. Compounds and pharmaceutical compositions thereof can promote degradation of the KRAS-G12D protein in a cell and are thus useful for treating, inhibiting, and preventing KRAS-G12D-associated diseases, disorders and conditions, including cancers.

Abstract: The disclosure relates to bifunctional CDK-modulating compounds having the structure W-L-T, where W is a targeting group that binds specifically to a CDK protein, T is an E3-ligase binding group, and L is absent or is a bivalent linking group that connects W and T together via a covalent linkage. Compounds and pharmaceutical compositions thereof can promote degradation of one or more CDK protein in a cell and are thus useful for treating, inhibiting, and preventing CDK-associated diseases, disorders and conditions, including cancers.

Abstract: A powder injection of a donepezil semi palmoxiric acid salt, a composition containing the same and a preparation method therefor. The powder injection contains donepezil semi palmoxiric acid salt crystals having an average particle size of 2-52 ?m.